As of May 2024 Twist Bioscience has a market cap of $2.73 Billion. This makes Twist Bioscience the world's 3677th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.73 B | 28.76% |
2023 | $2.12 B | 57.83% |
2022 | $1.34 B | -65.7% |
2021 | $3.92 B | -42.4% |
2020 | $6.81 B | 875.84% |
2019 | $0.69 B | 7.99% |
2018 | $0.64 B |
On May 19th, 2024 the market cap of Twist Bioscience was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Organovo ONVO | $11.77 M | -99.57% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.38 B | -86.11% | ๐ฌ๐ง UK |
Novavax NVAX | $1.91 B | -30.10% | ๐บ๐ธ USA |
Novocure
NVCR | $2.36 B | -13.55% | Jersey |